Seah H. Lim - Oct 9, 2022 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
Director
Signature
Seah H. Lim
Stock symbol
EMMA
Transactions as of
Oct 9, 2022
Transactions value $
$1,320,010
Form type
4
Date filed
12/19/2023, 07:44 PM
Previous filing
Oct 6, 2022
Next filing
Jan 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EMMA Common stock, $0.001 par value Purchase $2.79K +25.4K +65.97% $0.11 63.9K Oct 9, 2022 Direct
transaction EMMA Common stock, $0.001 par value Purchase $24.9K +92.1K +144.13% $0.27 156K Aug 25, 2023 Direct F1
transaction EMMA Common stock, $0.001 par value Purchase $3K +20K +12.82% $0.15 176K Aug 30, 2023 Direct
transaction EMMA Common stock, $0.001 par value Purchase $255 +1.7K +0.97% $0.15 178K Sep 5, 2023 Direct
transaction EMMA Common stock, $0.001 par value Sale -$660 -6K -3.38% $0.11 172K Dec 15, 2023 Direct
transaction EMMA Common stock, $0.001 par value Other $1.29M +4.45M +2590.23% $0.29 4.62M Dec 15, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EMMA Promissory Note due 9/16/2025 Other -240K -100% 0 Dec 15, 2023 Common Stock 240K $0.29 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.20 to $0.27, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
F2 The shares shown were issued in exchange for principal and accrued interest under the promissory note of the Issuer held by the reporting person referred to in footnote (2), below, which promissory note was surrendered by the reporting person for cancellation.
F3 Promissory Note due 9/16/2025 surrendered for cancellation in exchange for shares of common stock referred to in footnote (1) above.
F4 Represent shares previously issuable upon maturity of the Promissory Note due 9/16/2025.